Skip to content

Savara SVRA Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
TG Therapeutics logo
TG TherapeuticsTGTX
AdaptHealth logo
AdaptHealthAHCO

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+236%
Enterprise value$1.19B+224%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's amortization expense related to capitalized debt issuance costs?
Savara (SVRA) reported amortization expense related to capitalized debt issuance costs of $160K in Q1 2026.
How has Savara's amortization expense related to capitalized debt issuance costs changed year-over-year?
Savara's amortization expense related to capitalized debt issuance costs increased by 128.6% year-over-year, from $70K to $160K.
What is the long-term trend for Savara's amortization expense related to capitalized debt issuance costs?
Over 4 years (2021 to 2025), Savara's amortization expense related to capitalized debt issuance costs has grown at a -4.8% compound annual growth rate (CAGR), from $552K to $453K.